The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVan Elle Regulatory News (VANL)

Share Price Information for Van Elle (VANL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.00
Ask: 34.00
Change: -0.50 (-1.49%)
Spread: 2.00 (6.25%)
Open: 33.50
High: 33.50
Low: 33.00
Prev. Close: 33.50
VANL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission and First Day of Dealings on AIM

26 Oct 2016 07:00

RNS Number : 4435N
Van Elle Holdings PLC
26 October 2016
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

 

26 October 2016

 

Van Elle Holdings plc

 

("Van Elle" or the "Company")

 

Admission to Trading on AIM and First Day of Dealings

 

Van Elle, the geotechnical contractor offering a wide range of ground engineering techniques and services to customers in a variety of UK construction end markets, is pleased to announce the admission to trading on the AIM market of the London Stock Exchange plc of its entire issued ordinary share capital of 80,000,000 ordinary shares of 2 pence each (the "Shares"). Dealings in the Shares will commence at 08.00 a.m. today under the ticker VANL, with ISIN GB00BYX4TP46.

 

The Company has successfully raised £40 million (before expenses) by placing 30 million existing ordinary shares and 10 million new ordinary shares with investors at a placing price of 100 pence per share. Van Elle's market capitalisation on admission, based on the placing price, is £80 million. The Directors believe that admission to AIM will position Van Elle for its next stage of development, including further raising the profile of the Company, incentivising employees and providing it with a well-funded platform for future growth.

 

The total number of voting rights in the Company with effect from today is 80,000,000 Shares. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Peel Hunt LLP is acting as Nominated Advisor and sole broker to the Company.

 

Michael Ellis, Chairman, commented:

 

"We are absolutely delighted to have successfully brought Van Elle to the AIM market. We have worked tirelessly over the last thirty two years to build the company in to the established market leader that it is today. There is significant opportunity ahead and admission to trading on AIM will help us to accelerate the growth of the business."

 

Jon Fenton, Chief Executive, commented:

 

"We have a clear three-pronged strategy for growth centred on growing market share, developing new products, services and geographies and targeting bolt-on acquisitions. As a quoted company we will be able to fast-track the implementation of that strategy and I look forward to reporting on our progress as we embark on the next stage of our exciting journey."

 

 

The Company's AIM Admission Document can be viewed at: http://www.van-elle.co.uk

 

Ends

For further information please contact:

Van Elle Holdings plc

017 7358 0580

Jon Fenton, Chief Executive

Paul Pearson, Finance Director

Instinctif Partners (Financial Public Relations)

020 7457 2020

Mark Garraway

Rosie Driscoll

Peel Hunt LLP (Nominated Adviser and sole broker)

020 7418 8900

Charles Batten

Mike Bell

Alastair Rae

Justin Jones

Matthew Brooke-Hitching

Rickitt Mitchell & Partners Limited (Financial Adviser)

Neil Mitchell

Kaine Smith

 

finnCap Ltd (Lead Manager)

Chris Raggett

Giles Rolls

 

016 1834 0600

 

 

 

020 7220 0500

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKPDPABDDBKB
Date   Source Headline
24th Apr 20247:00 amRNSBlock listing Interim Review
25th Mar 20247:00 amRNSBlock listing Interim Review
24th Jan 20247:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Dec 20237:00 amRNSPCA Share Purchase
1st Dec 20237:00 amRNSTrading Update, Notice of Results & Investor Pres
30th Nov 20237:00 amRNSTotal Voting Rights
29th Nov 20235:57 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSPCA Share Purchase
26th Oct 20232:00 pmRNSAcquisition of Rock and Alluvium
10th Oct 20237:00 amRNSBlock Listing Application
25th Sep 20237:00 amRNSBlock listing Interim Review
21st Sep 202311:55 amRNSResult of AGM
21st Sep 20237:00 amRNSAGM Statement
5th Sep 20237:00 amRNSDirector/PDMR LTIP Awards
17th Aug 20237:00 amRNSNotice of AGM & posting of 2023 Annual Report
26th Jul 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
17th Jul 20237:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
14th Apr 20237:00 amRNSTrading Update
21st Mar 20237:00 amRNSBlock Listing Application
6th Feb 20237:00 amRNSMelloMonday Investor Presentation
25th Jan 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
22nd Nov 20227:00 amRNSTrading Update, Notice of Results & Investor Pres
4th Nov 20227:00 amRNSMelloLondon Investor Conference
10th Oct 20227:00 amRNSStrategic Contract Award - General Piling Division
29th Sep 20224:20 pmRNSResult of AGM
29th Sep 20227:00 amRNSAGM Statement
18th Aug 20227:00 amRNSAnnual Financial Report & Notice of AGM
3rd Aug 20227:00 amRNSFinal Results & Investor Presentation
21st Jun 20227:00 amRNSFramework Award & Rail Investor Presentation
17th May 20227:00 amRNSTrading Update, Notice of Results & Investor Pres
15th Mar 20222:05 pmRNSSecond Price Monitoring Extn
15th Mar 20222:00 pmRNSPrice Monitoring Extension
9th Feb 20227:00 amRNSPDMR Share Purchase
7th Feb 20221:19 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSInterim Results & Investor Presentation
22nd Nov 20217:00 amRNSPCA Share Purchase
19th Nov 20217:00 amRNSTrading Update & Notice of Results
12th Nov 20213:44 pmRNSHolding(s) in Company
10th Nov 20211:30 pmRNSHolding(s) in Company
15th Oct 202111:32 amRNSPCA Share Purchase
29th Sep 20211:30 pmRNSDirector/PDMR LTIP Awards
27th Sep 20215:44 pmRNSResult of AGM
27th Sep 20217:00 amRNSAGM Statement
1st Sep 20217:00 amRNSNotice of AGM and Posting of 2021 Annual Report
19th Aug 202110:40 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSFinal Results & Investor Presentation
12th Apr 20217:00 amRNSInvestor Presentation on Acquisition of ScrewFast
1st Apr 20217:00 amRNSAcquisition of ScrewFast Foundations Ltd
31st Mar 20212:48 pmRNSUpdate on Legacy Contract Dispute
31st Mar 202110:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.